Correlation Between Moderna and BIONTECH

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moderna and BIONTECH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moderna and BIONTECH into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moderna and BIONTECH SE DRN, you can compare the effects of market volatilities on Moderna and BIONTECH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moderna with a short position of BIONTECH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moderna and BIONTECH.

Diversification Opportunities for Moderna and BIONTECH

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Moderna and BIONTECH is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and BIONTECH SE DRN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BIONTECH SE DRN and Moderna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moderna are associated (or correlated) with BIONTECH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BIONTECH SE DRN has no effect on the direction of Moderna i.e., Moderna and BIONTECH go up and down completely randomly.

Pair Corralation between Moderna and BIONTECH

Assuming the 90 days trading horizon Moderna is expected to under-perform the BIONTECH. In addition to that, Moderna is 1.27 times more volatile than BIONTECH SE DRN. It trades about -0.06 of its total potential returns per unit of risk. BIONTECH SE DRN is currently generating about 0.0 per unit of volatility. If you would invest  5,390  in BIONTECH SE DRN on August 28, 2024 and sell it today you would lose (1,060) from holding BIONTECH SE DRN or give up 19.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Moderna  vs.  BIONTECH SE DRN

 Performance 
       Timeline  
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
BIONTECH SE DRN 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BIONTECH SE DRN are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BIONTECH sustained solid returns over the last few months and may actually be approaching a breakup point.

Moderna and BIONTECH Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moderna and BIONTECH

The main advantage of trading using opposite Moderna and BIONTECH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moderna position performs unexpectedly, BIONTECH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIONTECH will offset losses from the drop in BIONTECH's long position.
The idea behind Moderna and BIONTECH SE DRN pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world